Follow us :

Biopharmaceutical Development Driven by a Quest for a Better World

KinBio is a biopharmaceutical contract development and manufacturing company with a demonstrated track record of developing, manufacturing, and commercializing complex drugs, innovative biologics and biosimilars. As a part of a global pharmaceutical group, our capabilities cover quality development, manufacturing, and worldwide commercialization.

CDMO Services

Animal cell-based technologies

Cutting-Edge Tech

State-of-the-art facilities

One-Stop Shop

Comprehensive services in one place

Our Services

What Service We Offer


We excel in developing and optimizing technological platforms for competitive animal cell-based processes and consistent product quality.


Our quality system is compliant with EMA, USFDA and is routinely inspected by Israel MOH to ensure meeting the highest quality standards.

CDMO Services

We offer end-to-end services for protein therapeutics, from concept to commercialization.

Complex Generics Facility

Our chemical synthesis line is modernly equipped for sophisticated API manufacturing.

Biopharmaceuticals Facility

Our multi-product biologics manufacturing suite enables production of substantial quantities of drug bulk substances, including hard-to-express proteins.

Cultured Meat Services

Our vast experience in animal cells-based development and manufacturing with our modern infrastructure makes us the ideal partner to companies developing next generation cultivated meat.

Your Partner for Life-Changing Solutions

Let us harness our experience and capabilities to bring your brilliant ideas to fulfillment.

With our efficient process development and quality manufacturing along with the good advice and close guidance by our dedicated team, you can be rest assured that your project will timely meet its goals.


Contact us to learn more

Contact us to learn more about how KinBio can take your product from the earliest stages of development to market release. 

KinBio Headquarters

KinBio Europe